Rita Balice-Gordon
Director/Miembro de la Junta en COLLEGIUM PHARMACEUTICAL, INC. .
Fortuna: 2 M $ al 31/05/2024
Cargos activos de Rita Balice-Gordon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Miembro de la Junta | 24/09/2020 | - |
| Independent Dir/Board Member | 24/09/2020 | - | |
Muna Therapeutics ApS
 Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Director/Miembro de la Junta | 01/05/2020 | - |
| Director Ejecutivo | - | - | |
| Director Técnico/Científico/I+D | 01/05/2020 | - | |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Director/Miembro de la Junta | 12/05/2021 | - |
Historial de carrera de Rita Balice-Gordon
Antiguos cargos conocidos de Rita Balice-Gordon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
| Perelman School of Medicine | Corporate Officer/Principal | - | - |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | - | - |
Formación de Rita Balice-Gordon.
| Northwestern University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Dinamarca | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Muna Therapeutics ApS
Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Health Services |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Rita Balice-Gordon
- Experiencia
